Production and Characterization of a Budesonide Nanosuspension for Pulmonary Administration
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanosuspensions as particulate drug formulations in therapy
Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370
Self-citationLiversidge, G. G., & Cundy, K. C. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00122-y · Cited by 739
Nanosuspensions for the Formulation of Poorly Soluble Drugs
Müller, R., Jacobs, C., & Kayser, O. (2000) · Drugs and the Pharmaceutical Sciences · doi:10.1201/b14005-13 · Cited by 501
Self-citationNanosuspensions for the formulation of poorly soluble drugs
Müller, R. H., & Peters, K. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00311-6 · Cited by 480
Self-citationPharmaceutical Inhalation Aerosol Technology
(2003) · CRC Press eBooks · doi:10.1201/9780203912898 · Cited by 292
Merisko-Liversidge, E., Sarpotdar, P., Bruno, J., Hajj, S., Wei, L., Peltier, N., Rake, J., Shaw, J. M., Pugh, S., Polin, L., et al. (1996) · Pharmaceutical Research · doi:10.1023/a:1016051316815 · Cited by 230
Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract
Ponchel, G., Montisci, M.-J., Dembri, A., Durrer, C., & Duchêne, D. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00098-2 · Cited by 191
Inhibition of Sulfathiazole Crystal Growth by Polyvinylpyrrolidone
Simonelli, A. P., Mehta, S. C., & Higuchi, W. I. (1970) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600590512 · Cited by 177
Hydrosols : alternatives for the parenteral application of poorly water soluble drugs
Gassmann, P., List, M., Schweitzer, A., & Sucker, H. (1994) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 103
Solubility of Pharmaceutical Solids
Grant, D. J. W. (1995) · Drugs and the pharmaceutical sciences · doi:10.1201/b14204-12 · Cited by 69
Cited by
Drug Solubility: Importance and Enhancement Techniques
Savjani, K. T., Gajjar, A. K., & Savjani, J. K. (2012) · ISRN Pharmaceutics · doi:10.5402/2012/195727 · Cited by 2,004
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,524
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
Self-citationPhysical and chemical stability of drug nanoparticles
Wu, L., Zhang, J., & Watanabe, W. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.001 · Cited by 993
Nanosuspensions: a promising drug delivery strategy
Patravale, V. B., Date, A. A., & Kulkarni, R. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023691 · Cited by 904
Van Eerdenbrugh, B., Van den Mooter, G., & Augustijns, P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.023 · Cited by 717
Inhaled nanoparticles—A current review
Yang, W., Peters, J. I., & Williams, R. O. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.02.011 · Cited by 666
Weber, S., Zimmer, A., & Pardeike, J. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.08.013 · Cited by 568
Shameli, K., Bin Ahmad, M., Jazayeri, S. D., Sedaghat, S., Shabanzadeh, P., Jahangirian, H., Mahdavi, M., & Abdollahi, Y. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13066639 · Cited by 556
Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs
Junyaprasert, V. B., & Morakul, B. (2015) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.08.005 · Cited by 443
Drug nanocrystals in the commercial pharmaceutical development process
Möschwitzer, J. P. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.034 · Cited by 432
Gao, L., Zhang, D., & Chen, M. (2008) · Journal of Nanoparticle Research · doi:10.1007/s11051-008-9357-4 · Cited by 420
Emerging role of nanosuspensions in drug delivery systems
Jacob, S., Nair, A. B., & Shah, J. (2020) · Biomaterials Research · doi:10.1186/s40824-020-0184-8 · Cited by 415
Mechanical properties and peculiarities of molecular crystals
Awad, W. M., Davies, D. W., Kitagawa, D., Mahmoud Halabi, J., Al-Handawi, M. B., Tahir, I., Tong, F., Campillo-Alvarado, G., Shtukenberg, A. G., Alkhidir, T., et al. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00481j · Cited by 392
Pandey, R. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg477 · Cited by 388
Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery
Gupta, H., Aqil, M., Khar, R. K., Ali, A., Bhatnagar, A., & Mittal, G. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.10.004 · Cited by 367
Drug nanocrystals: in vivo performances.
Gao, L., Liu, G., Ma, J., Wang, X., Zhou, L., & Li, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.013 · Cited by 347
Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis
Zahoor, A., Sharma, S., & Khuller, G. K. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.07.012 · Cited by 314
“In recent years, one of the best ways to achieve higher drug levels in the lungs has been the development of new formulations (nanoparticle-based) that are directly delivered to the lungs via the aerosol route [9].”
BackgroundNanoparticle formulations in pulmonary drug delivery
Bailey, M. M., & Berkland, C. J. (2009) · Medicinal Research Reviews · doi:10.1002/med.20140 · Cited by 302
Kamble, S., Agrawal, S., Cherumukkil, S., Sharma, V., Jasra, R. V., & Munshi, P. (2022) · ChemistrySelect · doi:10.1002/slct.202103084 · Cited by 300
Lipid-Based Nanoparticles for Drug Delivery Systems
Samimi, S., Maghsoudnia, N., Eftekhari, R. B., & Dorkoosh, F. (2019) · Characterization and Biology of Nanomaterials for Drug Delivery · doi:10.1016/b978-0-12-814031-4.00003-9 · Cited by 266
Kakran, M., Sahoo, N. G., Tan, I.-L., & Li, L. (2012) · Journal of Nanoparticle Research · doi:10.1007/s11051-012-0757-0 · Cited by 265
Pandey, R., Zahoor, A., Sharma, S., & Khuller, G. K. (2003) · Tuberculosis · doi:10.1016/j.tube.2003.07.001 · Cited by 220
Metadata
- Authors
- Jacobs, C., & Müller, R. H.
- Venue
- Pharmaceutical Research
- Published
- 2002-02
- Volume
- 19
- Issue
- 2
- Pages
- 189-194
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1591730307
- Cited by
- 439
- References
- 11
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.